Organovo Holdings ONVO, Speculative 3D Biomedical Stock

704 8 23
Organovo is the first company to succesfully print human tissue, and now offer a real product: exVive 3D Human Liver Tissue. With results in less than 1 month companies can send protential blockbuster drugs to be tested by Organovo for only $175,000. Bypassing the old procedure of human trials and FDA approvals, Organovo products can eliminate years and billions of dollars in research and development. Biotech and drug companies can right away find out if a drug has a potential impact, good or bad. Organovo also has plans in developping other tissues that can be tested next year. If more tissue products are released next year you can expect some big moves in ONVO             . However, revenues from these products will come in slowly. So ONVO             is regarded as a very speculative future growth play.

ONVO             as of Dec. 1, 2014
24.56 % short interest
73 million float

ONVO broke key support. Looks to be headed for prior support low 5.25
I like onvo too, thanks
Thanks for the post
No problem. I will keep on tracking this one.
+1 Reply

ONVO has reacted to weekly band sqz's in the past.
+1 Reply
...this stock deserves a 3D chart outlook
+3 Reply
Yes a 3D look. Nice looking candle last week. Don't want it to get too far ahead. Rather see it hit a resistance and build support for a much larger move later on.
+1 Reply
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out